Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 23, 2020
AvKARE is voluntarily recalling one lot of Sildenafil 100 mg tablets and one lot of Trazodone 100mg tablets to the consumer level.
read more
Avomeen Analytical Services has hired Khanh Ngo Courtney as its Biological Chemistry Project Director. Through this newly created position, Courtney will help grow Avomeen’s large-molecule and protein therapeutics business segment by partnering with ...
read more
Avondale Pharmaceuticals announced an exclusive, product development partnership with Oxford Pharmaceuticals, a pharmaceutical manufacturer and distributor based in Birmingham, AL.
read more
Avrio Biopharmaceuticals, LLC, a leading global cGMP contract aseptic manufacturing organization, announced the appointment of Laura Jones, Ph.D., J.D., M.S., M.B.A., as Vice President of Quality and Regulatory Affairs. Dr. Jones will be responsible ...
read more
Wednesday, December 04, 2019
AWS has announced a multi-year strategic collaboration with Novartis to develop the pharmaceutical company’s core pharmaceutical manufacturing, supply chain, and delivery operations using AWS’s portfolio of cloud services.
read more
Axcelead Drug Discovery Partners, Inc. has entered into a drug discovery service agreement with Astellas Pharma, Inc. to explore new candidate compounds for targeted protein degraders.
read more
axialHealthcare announced new capabilities to effectively treat opioid use disorder (OUD) with the launch of its latest operating platform, axialINSIGHT 3.0
read more
Tuesday, January 08, 2019
Industrial wastewater treatment provider Axine Water Technologies has signed a multi-year wastewater services agreement with a pharmaceutical manufacturer.
read more
Axio BioPharma and Likarda announced a strategic partnership to accelerate innovation in biologic drug development. This collaboration will integrate Likarda's proprietary delivery technologies with Axio's manufacturing capabilities, creating a more ...
read more
Monday, September 30, 2024
Axio BioPharma announced that it is now accepting recombinant protein manufacturing projects. Located within Forward BIOLABS at 504 South Rosa Rd., Suite 200, Madison, WI, Axio BioPharma is poised to meet the growing demands of the biopharmaceutical ...
read more
Axol Bioscience launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease.
read more
Axol Bioscience, a biotechnology company specializing in the supply of primary and stem cell-derived human cells for use in disease modelling and drug discovery, announces the launch of its Custom Cell and Tissue Sourcing service.
read more
Axol Bioscience and CENSO Biotechnologies announced the two companies have signed a merger agreement.
read more
Axovant Gene Therapies has signed a strategic partnership with Yposkesi a CDMO for preferred access and reserved capacity for cGMP grade viral vector production.
read more
Axplora has announced a major milestone in its $60 million investment program to expand highly potent API (HPAPI) development and manufacturing at its Farmabios site in Gropello Cairoli, Italy.
read more